Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NSAID use lowers relative risk of developing Alzheimer's -- NIA prospective study.

This article was originally published in The Tan Sheet

Executive Summary

NSAID USE LOWERS RELATIVE RISK OF ALZHEIMER's DISEASE among participants of the National Institute on Aging's Baltimore Longitudinal Study of Aging. The study followed 1,686 participants from 1980 to 1995, comparing risks of developing Alzheimer's disease in users of aspirin or other nonsteroidal anti-inflammatory drugs and users of acetaminophen. A report on the study by Walter Stewart, PhD, Johns Hopkins, et al., is published in the March issue of Neurology.

You may also be interested in...



NSAID Use For Alzheimer’s Prevention Future Research Suggested In JAMA

Future research on non-steroidal anti-inflammatory drugs and Alzheimer's disease may need to focus on prevention rather than treatment, an editorial in the June 4 Journal of the American Medical Association suggests

NSAID Use For Alzheimer’s Prevention Future Research Suggested In JAMA

Future research on non-steroidal anti-inflammatory drugs and Alzheimer's disease may need to focus on prevention rather than treatment, an editorial in the June 4 Journal of the American Medical Association suggests

NSAID Use For Alzheimer’s Prevention Future Research Suggested In JAMA

Future research on non-steroidal anti-inflammatory drugs and Alzheimer's disease may need to focus on prevention rather than treatment, an editorial in the June 4 Journal of the American Medical Association suggests

Related Content

Topics

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel